Getting personal: Considering variable interindividual responsiveness to dietary lipid-lowering therapies

Current Opinion in Lipidology

Volumn 22, Issue 1, 2011, Pages 37-42

  Rideout, Todd C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

dietary lipid lowering therapies; interindividual responsiveness; nutrigenomics

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; FATTY ACID BINDING PROTEIN 2; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PHYTOSTEROL; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; COPY NUMBER VARIATION; DIABETES MELLITUS; DIETARY FIBER; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; EPIGENETICS; EXERCISE; GENETIC MARKER; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIPID ABSORPTION; LIPID COMPOSITION; LIPID METABOLISM; LOW FAT DIET; METABOLIC SYNDROME X; NONHUMAN; NUTRITIONAL SUPPORT; OBESITY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOYBEAN MILK; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

DIET THERAPY; HUMANS; LIPIDS;

EID: 78751624339     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283414e71     Document Type: Article

References (41)

1. Lairon D, Defoort C, Martin JC, et al. Nutrigenetics: links between genetic background and response to Mediterranean-type diets. Public Health Nutr 2009; 12:1601-1606.
2. Marinangeli CP, Jones PJ, Kassis AN, Eskin MN. Policosanols as nutraceuticals: fact or fiction. Crit Rev Food Sci Nutr 2010; 50:259-267.
3. Zivkovic AM, Wiest MM, Nguyen U, et al. Assessing individual metabolic responsiveness to a lipid challenge using a targeted metabolomic approach. Metabolomics 2009; 5:209-218.
4. Bach RG. Heterogeneity of response to lipid-lowering therapy. J Am Coll Cardiol 2001; 38:2136-2137.
5. Rideout TC, Chan YM, Harding SV, Jones PJ. Low and moderate-fat plant sterol fortified soymilk in modulation of plasma lipids and cholesterol kinetics in subjects with normal to high cholesterol concentrations: report on two randomized crossover studies. Lipids Health Dis 2009; 8:45.
6. Lovegrove JA, Gitau R. Personalized nutrition for the prevention of cardiovascular disease: a future perspective. J Hum Nutr Diet 2008; 21:306-316.
7. Ordovas JM. Genotype-phenotype associations: modulation by diet and obesity. Obesity (Silver Spring) 2008; 16 (Suppl 3):S40-S46.
8. St-Onge MP, Zhang S, Darnell B, Allison DB. Baseline serum C-reactive protein is associated with lipid responses to low-fat and high-polyunsaturated fat diets. J Nutr 2009; 139:680-683.
9. Moreno JA, Perez-Jimenez F, Moreno-Luna R, et al. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects. Br J Nutr 2009; 101:1745-1752.
10. Gomez P, Perez-Martinez P, Marin C, et al. APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults. J Nutr 2010; 140:773-778.
11. Perez-Martinez P, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J. Update on genetics of postprandial lipemia. Atheroscler Suppl 2010; 11:39-43.
12. Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 2007; 98:458-473.
13. Schoppen S, Perez-Granados AM, Navas-Carretero S, Vaquero MP. Postprandial lipaemia and endothelial adhesion molecules in pre and postmeno-pausal Spanish women. Nutr Hosp 2010; 25:256-261.
14. Mattar M, Obeid O. Fish oil and the management of hypertriglyceridemia. Nutr Health 2009; 20:41-49.
15. Caslake MJ, Miles EA, Kofler BM, et al. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 2008; 88:618-629.
16. Maki KC, Dicklin MR, Davidson MH, et al. Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy. Am J Cardiol 2010; 105:1409-1412.
17. Kohler A, Bittner D, Low A, von Schacky C. Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr 2010; 104:729-736.
18. Metherel AH, Armstrong JM, Patterson AC, Stark KD. Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. Prostaglandins Leukot Essent Fatty Acids 2009; 81:23-29.
19. Olano-Martin E, Anil E, Caslake MJ, et al. Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 2010; 209:104-110.
20. Pishva H, Mahboob SA, Mehdipour P, et al. Fatty acid-binding protein-2 genotype influences lipid and lipoprotein response to eicosapentaenoic acid supplementation in hypertriglyceridemic subjects. Nutrition 2010; 26:1117-1121.
21. Prasad K. Flaxseed and cardiovascular health. J Cardiovasc Pharmacol 2009; 54:369-377.
22. Pan A, Yu D, Demark-Wahnefried W, et al. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 2009; 90:288-297.
23. Patenaude A, Rodriguez-Leyva D, Edel AL, et al. Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject. Eur J Clin Nutr 2009; 63:1123-1129.
24. Rideout TC, Harding SV, Fan MZ, Jones PJH. Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: current understandings and future research priorities. Vasc Health Risk Manage 2008; 4:1023-1033.
25. Papathanasopoulos A, Camilleri M. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology 2010; 138:65-72; e1-e2.
26. Sola R, Bruckert E, Valls RM, et al. Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: a randomised trial. Atherosclerosis 2010; 211:630-637.
27. Jones PJ, AbuMweis SS. Phytosterols as functional food ingredients: linkages to cardiovascular disease and cancer. Curr Opin Clin Nutr Metab Care 2009; 12:147-151.
28. Jakulj L, Trip MD, Sudhop T, et al. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J Lipid Res 2005; 46:2692-2698.
29. Rideout TC, Harding SV, Mackay D, et al. High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy. Am J Clin Nutr 2010; 92:41-46.
30. Simonen PP, Gylling H, Miettinen TA. Body weight modulates cholesterol metabolism in noninsulin dependent type 2 diabetics. Obes Res 2002; 10:328-335.
31. Thuluva SC, Igel M, Giesa U, et al. Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine. Int J Clin Pharmacol Ther 2005; 43:305-310.
32. Rideout TC, Harding SV, Jones PJ. Consumption of plant sterols reduces plasma and hepatic triglycerides and modulates the expression of lipid regulatory genes and de novo lipogenesis in C57BL/6J mice. Mol Nutr Food Res 2010; 54 (Suppl 1):S7-S13.
33. Calpe-Berdiel L, Escola-Gil JC, Ribas V, et al. Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet. Atherosclerosis 2005; 181:75-85.
34. Lees AM, Mok HY, Lees RS, et al. Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 1977; 28:325-338.
35. Clifton PM, Mano M, Duchateau GS, et al. Dose-response effects ofdifferent plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. Eur J Clin Nutr 2008; 62:968-977.
36. Plana N, Nicolle C, Ferre R, et al. Plant sterol-enriched fermented milk enhances the attainment of LDL-cholesterol goal in hypercholesterolemic subjects. Eur J Nutr 2008; 47:32-39.
37. Jones PJ, Raeini-Sarjaz M, Ntanios FY, et al. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 2000; 41:697-705.
38. Plat J, Brufau G, Dallinga-Thie GM, et al. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J Nutr 2009; 139:1143-1149.
39. Naumann E, Plat J, Kester AD, Mensink RP. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr 2008; 27:117-126.
40. Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols as cholesterol-lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 2008; 52:8.
41. Berger A, Jones PJ, Abumweis SS. Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Lipids Health Dis 2004; 3:5.